AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies von Pammaraju, Naveen, Kantarjian, Hagop, Sweet, Kendra, Wang, Eunice S., Lane, Andrew A., Ali, Haris, Stein, Anthony S., Yacoub, Abdulraheem, Rizzieri, David, Vasu, Sumithira, Gupta, Vikas, Lee, Sangmin, Schiller, Gary J., Foran, James M., Taparia, Minakshi S., Rosenblat, Todd L., Walter, Roland B., Sieminski, Deborah, Anant, Madhu, Patnaik, Mrinal M., Mughal, Tariq I., Konopleva, Marina

Volltext

Poster: AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies von Pammaraju, Naveen, Kantarjian, Hagop, Sweet, Kendra, Wang, Eunice S., Lane, Andrew A., Ali, Haris, Stein, Anthony S., Yacoub, Abdulraheem, Rizzieri, David, Vasu, Sumithira, Gupta, Vikas, Lee, Sangmin, Schiller, Gary J., Foran, James M., Taparia, Minakshi S., Rosenblat, Todd L., Walter, Roland B., Sieminski, Deborah, Anant, Madhu, Patnaik, Mrinal M., Mughal, Tariq I., Konopleva, Marina

Volltext

A Global Proteomic Pathway Map In Acute Myeloid Leukemia (AML) von Hu, Chenyu W, Qutub, Amina A, Qiu, Yihua, Yoo, Suk Young, Zhang, Nianxiang, Pammaraju, Naveen, DiNardo, Courtney D., Coombes, Kevin R., Kornblau, Steven M.

Volltext